Cerenome is trading at $0.63, down 5.96%, with healthcare-sector weakness adding pressure. - Healthcare stocks are down 1.48%; the broader market is mixed-to-higher and does not explain the decline as well. - No fresh Cerenome-specific catalyst was identified for November 6. The Aetna agreement was announced November 4, so it is prior news, not a new trigger. - Cerenome fell 24.87% on November 5, extending a sharp recent decline.